New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Etigilimab Plus Nivolumab Shows Activity in Recurrent/Advanced Solid Tumors, and Possible Biomarkers Emerge

Etigilimab Plus Nivolumab Shows Activity in Recurrent/Advanced Solid Tumors, and Possible Biomarkers Emerge

October 21, 2023Megan HollaschCombination treatment with etigilimab and nivolumab was well tolerated in patients with recurrent or advanced solid tumors and promising efficacy was seen for patients wi
World medicine November 23,2023
Etigilimab Plus Nivolumab Shows Activity in Recurrent/Advanced Solid Tumors, and Possible Biomarkers Emerge

Etigilimab Plus Nivolumab Shows Activity in Recurrent/Advanced Solid Tumors, and Possible Biomarkers Emerge

October 21, 2023Megan HollaschCombination treatment with etigilimab and nivolumab was well tolerated in patients with recurrent or advanced solid tumors and promising efficacy was seen for patients wi
World medicine November 23,2023
Menu calorie labeling may reduce lower obesity-related cancer rates and healthcare costs

Menu calorie labeling may reduce lower obesity-related cancer rates and healthcare costs

Specifying the number of calories for each item on restaurant menus is likely linked to lower rates of cancers associated with obesity and attendant healthcare costs in the US, suggests a modeling stu
World medicine November 23,2023
Menu calorie labeling may reduce lower obesity-related cancer rates and healthcare costs

Menu calorie labeling may reduce lower obesity-related cancer rates and healthcare costs

Specifying the number of calories for each item on restaurant menus is likely linked to lower rates of cancers associated with obesity and attendant healthcare costs in the US, suggests a modeling stu
World medicine November 23,2023
Frontline Enfortumab Vedotin Plus Pembrolizumab Elicits OS Improvement in Advanced Urothelial Carcinoma

Frontline Enfortumab Vedotin Plus Pembrolizumab Elicits OS Improvement in Advanced Urothelial Carcinoma

October 22, 2023Jason BroderickFrontline treatment with the combination of enfortumab vedotin-ejfv and pembrolizumab led to a statistically significant improvement in overall survival vs chemotherapy
World medicine November 23,2023
Frontline Enfortumab Vedotin Plus Pembrolizumab Elicits OS Improvement in Advanced Urothelial Carcinoma

Frontline Enfortumab Vedotin Plus Pembrolizumab Elicits OS Improvement in Advanced Urothelial Carcinoma

October 22, 2023Jason BroderickFrontline treatment with the combination of enfortumab vedotin-ejfv and pembrolizumab led to a statistically significant improvement in overall survival vs chemotherapy
World medicine November 23,2023
Bonn researchers elucidate a mechanism underlying cisplatin resistance in testicular cancer

Bonn researchers elucidate a mechanism underlying cisplatin resistance in testicular cancer

Cisplatin is used successfully in the chemotherapy of testicular cancer. However, patients who develop resistance to the cytostatic drug urgently need alternative therapy options. Researchers at the U
World medicine November 23,2023
Bonn researchers elucidate a mechanism underlying cisplatin resistance in testicular cancer

Bonn researchers elucidate a mechanism underlying cisplatin resistance in testicular cancer

Cisplatin is used successfully in the chemotherapy of testicular cancer. However, patients who develop resistance to the cytostatic drug urgently need alternative therapy options. Researchers at the U
World medicine November 23,2023
Point-of-care testing can be effective for improving access to cancer genetic services

Point-of-care testing can be effective for improving access to cancer genetic services

Genetic testing for hereditary cancers, such as breast, colon, pancreatic, and ovarian cancer, helps at-risk individuals understand their familial risk for these diseases and make informed decisions a
World medicine November 23,2023
Point-of-care testing can be effective for improving access to cancer genetic services

Point-of-care testing can be effective for improving access to cancer genetic services

Genetic testing for hereditary cancers, such as breast, colon, pancreatic, and ovarian cancer, helps at-risk individuals understand their familial risk for these diseases and make informed decisions a
World medicine November 23,2023
New sensing platform for detecting biological markers related to cancers

New sensing platform for detecting biological markers related to cancers

When doctors are examining suspected cancer cases, they turn to biomarker tests to help make a diagnosis.With a testing system and patient samples, physicians can investigate potential leads, narrowin
World medicine November 23,2023
New sensing platform for detecting biological markers related to cancers

New sensing platform for detecting biological markers related to cancers

When doctors are examining suspected cancer cases, they turn to biomarker tests to help make a diagnosis.With a testing system and patient samples, physicians can investigate potential leads, narrowin
World medicine November 23,2023
Dara-KRd Quadruplet Makes Waves in Newly Diagnosed Multiple Myeloma

Dara-KRd Quadruplet Makes Waves in Newly Diagnosed Multiple Myeloma

August 25, 2023Megan HollaschLuciano J. Costa, MD, PhD, discussed extended follow-up data from the trial and explained how the results may affect frontline treatment decisions in multiple myeloma.Luci
World medicine November 23,2023
Dara-KRd Quadruplet Makes Waves in Newly Diagnosed Multiple Myeloma

Dara-KRd Quadruplet Makes Waves in Newly Diagnosed Multiple Myeloma

August 25, 2023Megan HollaschLuciano J. Costa, MD, PhD, discussed extended follow-up data from the trial and explained how the results may affect frontline treatment decisions in multiple myeloma.Luci
World medicine November 23,2023
ColoAlert’s Novel mRNA Biomarkers Demonstrate Sensitivity, Specificity in Detecting CRC, Advanced Adenoma

ColoAlert’s Novel mRNA Biomarkers Demonstrate Sensitivity, Specificity in Detecting CRC, Advanced Adenoma

October 18, 2023Chris RyanThe novel mRNA biomarkers in the noninvasive ColoAlert® screening test displayed sensitivity and specificity for detecting colorectal cancer and advanced adenomas that could
World medicine November 23,2023
ColoAlert’s Novel mRNA Biomarkers Demonstrate Sensitivity, Specificity in Detecting CRC, Advanced Adenoma

ColoAlert’s Novel mRNA Biomarkers Demonstrate Sensitivity, Specificity in Detecting CRC, Advanced Adenoma

October 18, 2023Chris RyanThe novel mRNA biomarkers in the noninvasive ColoAlert® screening test displayed sensitivity and specificity for detecting colorectal cancer and advanced adenomas that could
World medicine November 23,2023
Pragmatica-Lung Study aims to increase accessibility to cancer clinical trials

Pragmatica-Lung Study aims to increase accessibility to cancer clinical trials

The National Cancer Institute, part of the National Institutes of Health (NIH), has helped launch a phase 3 randomized clinical trial (NCT05633602) of a two-drug combination to treat patients with adv
World medicine November 23,2023
Pragmatica-Lung Study aims to increase accessibility to cancer clinical trials

Pragmatica-Lung Study aims to increase accessibility to cancer clinical trials

The National Cancer Institute, part of the National Institutes of Health (NIH), has helped launch a phase 3 randomized clinical trial (NCT05633602) of a two-drug combination to treat patients with adv
World medicine November 23,2023
CGX1321 Demonstrates Safety and Promising Activity in Advanced GI Cancers

CGX1321 Demonstrates Safety and Promising Activity in Advanced GI Cancers

August 21, 2023Courtney FlahertyMarios Giannakis, MD, PhD, discusses how targeting the WNT signaling pathway could harness a previously underutilized pathway involved in GI tumor development, spotligh
World medicine November 23,2023
CGX1321 Demonstrates Safety and Promising Activity in Advanced GI Cancers

CGX1321 Demonstrates Safety and Promising Activity in Advanced GI Cancers

August 21, 2023Courtney FlahertyMarios Giannakis, MD, PhD, discusses how targeting the WNT signaling pathway could harness a previously underutilized pathway involved in GI tumor development, spotligh
World medicine November 23,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com